What is an appropriate treatment plan for a 19-year-old male with a positive nucleic acid amplification test (NAA) for Neisseria gonorrhoeae and a negative NAA for Chlamydia trachomatis that the patient can adhere to?

Treatment for Gonorrhea in a 19-Year-Old Male

Treat this patient with a single intramuscular dose of ceftriaxone 500 mg, and since the chlamydia test is negative, no additional azithromycin or doxycycline is needed for chlamydia coverage. 1

Primary Treatment Recommendation

The standard first-line therapy for uncomplicated gonorrhea when chlamydia is ruled out is:

• Ceftriaxone 500 mg intramuscularly as a single dose

This represents the current CDC-recommended regimen for gonorrhea treatment 1. Since your patient tested negative for Chlamydia trachomatis by NAA testing, you can avoid unnecessary antibiotic exposure by omitting empiric chlamydia treatment—this is good antimicrobial stewardship 1.

Key Clinical Considerations

Site of Infection Matters

• Determine the anatomical site(s) of infection through history (urethral, rectal, pharyngeal)
• Pharyngeal gonorrhea is particularly important: If there's any possibility of pharyngeal involvement based on sexual practices, ensure the patient was tested at that site, as pharyngeal infections are more difficult to treat and are a major source of treatment failure 2
• Most urogenital infections respond well to standard ceftriaxone dosing, even with some in-vitro resistance 2

Partner Management

• Both partners must be treated simultaneously to prevent reinfection 3
• Advise sexual abstinence until 7 days after treatment completion and until all partners are treated
• Consider expedited partner therapy where legally permissible

Follow-Up Testing

• Test of cure is recommended for all gonorrhea cases 3
• Retest 3 months after treatment due to high reinfection rates in young adults
• If symptoms persist after treatment, obtain culture with antimicrobial susceptibility testing and report to public health within 24 hours 2

Common Pitfalls to Avoid

1. Don't add azithromycin unnecessarily: Since chlamydia is negative by NAA testing (which has excellent sensitivity and specificity), adding azithromycin 1-2g would be inappropriate antibiotic overuse 1

2. Don't miss pharyngeal infection: If the patient engaged in oral sex and wasn't tested pharyngeally, consider testing that site—gentamicin and spectinomycin have poor pharyngeal efficacy if treatment failure occurs 2

3. Don't forget screening for other STIs: Test for HIV, syphilis, and consider hepatitis B vaccination status given his age and STI diagnosis 4

Treatment Failure Protocol

If the patient remains symptomatic 3-7 days post-treatment:

• Obtain culture with antimicrobial susceptibility testing immediately
• Report to local public health within 24 hours
• Consider retreatment with gentamicin 240 mg IM + azithromycin 2g orally (though note gentamicin has poor pharyngeal efficacy) 2
• Consult infectious disease or STI specialist

Patient Adherence Factors

For a 19-year-old male, single-dose IM ceftriaxone offers excellent adherence advantages:

• One-time administration in clinic ensures completion
• No multi-day oral regimen to remember
• Immediate treatment prevents loss to follow-up (which is common in this population) 4